Skip to content

PHARMAFORM

Absorbed by 3P DALHEM on 07-01-2015 KBO/BCE: BE 0475.742.240

Annual accounts 2013

full format, filed on 25-08-2014, 25 days late
€123,797
▲ 55.1%
€18,508
▼ 62.0%
€1,609
▼ 97.1%
-€24,750
▼ €31,896
16.5%
▲ 0.4 percentage points
0.79
▼ 0.30

Turnover is estimated at about €320,000, probably between €190,000 and €600,000.

Balance sheet

balance sheet total €471,917 on 31-12-2013
What the company ownsHow it is paid for

in euro

in euro

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend20132012201120102009200820072006
53,07072,32283,14732,07335,57181,48461,945-46,861
36,17178,24265,56212,28015,24354,10634,143-59,649
32,90013,46700000525,000
-4,786-11,21616,801312-3,646---
-24,7507,14650,02717,34435,60751,118-33,451-45,639
16.5%16.1%4.1%-3.6%-0.8%1.3%-6.2%-7.7%
0.791.081.471.201.792.870.400.04
5.085.2323.48--73.51--
2.1%71.9%183.9%--395.6%--
0.3%11.5%7.5%-2.8%-2.2%5.3%1.6%-17.7%

EBIT margin not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend20132012201120102009200820072006
Balance sheet: assets
20/58 471,917473,415523,212496,957500,567524,712494,990500,751
21/28 379,708381,370367,500393,750420,000446,250472,500498,750
22/27 379,708381,370367,500393,750420,000446,250472,500498,750
22 357,774381,370367,500393,750420,000446,250472,500498,750
23 4,600------0
24 17,334-------
29/58 92,20992,045155,712103,20780,56778,46222,4902,001
40/41 91,05386,103138,55498,85080,52274,77122,4902,001
40 24,73751,10349,53319,828012,700--
41 66,31635,00089,02179,02280,52262,07122,4902,001
54/58 1,1565,94217,158357453,691-0
490/1 ---4,000----
Balance sheet: equity and liabilities
10/49 471,917473,415523,212496,957500,567524,712494,990500,751
10/15 77,63176,02221,377-17,935-3,9657,042-30,814-38,706
10/11 70,00070,00070,00070,00070,00070,00060,00060,000
100 70,00070,00070,00070,00070,00070,00070,00070,000
101 -----010,00010,000
13 1,4971,4971,4971,4971,4971,4971,4971,497
130 1,4971,4971,4971,4971,4971,4971,4971,497
14 6,1344,525-50,120-89,432-75,462-64,455-92,311-100,204
17/49 394,286397,393501,835514,892504,532517,670525,803539,458
17 277,327312,494395,841428,372459,572490,325466,814491,817
170/4 277,327312,494395,841428,372459,572490,325466,814491,817
42/48 116,95984,899105,68585,86344,96027,34555,94147,641
42 35,16733,56432,53231,20029,88026,48925,00323,742
43 ------36
430/8 -----036
44 19,27318,43810,353-9,324-529-
440/4 19,27318,43810,353-9,3240529-
45 13,0283,66715,0371,445----
450/3 13,0283,66715,0371,445----
47/48 49,49129,23047,76353,2185,75685630,40623,893
492/3 --309657-03,0490
Income statement
76A -24,000------
9900 123,79779,81090,65639,11543,65590,64269,16320,943
630 34,56223,59726,25026,25026,25026,25026,25028,886
631/4 58,000-------
640/8 12,7277,4887,5097,0428,0849,1577,21867,804
66A ------0240
9901 18,50848,72556,8975,8239,32155,23435,695-75,747
75/76B 631610-910136
75 631610-910136
65/66B 16,88617,09517,59419,79320,33727,38727,81212,554
65 16,88617,09517,59419,79320,33727,38727,81212,554
9903 1,62855,94639,313-13,970-11,00727,8577,896-88,535
67/77 191,3011-0131
9904 1,60954,64539,312-13,970-11,00727,8567,893-88,535
9905 1,60954,64539,312-13,970-11,00727,8567,893-88,535
Appropriation of the result
9906 6,1344,525-50,120-89,432-75,462-64,455-92,311-100,204
Document PDFPDFPDFPDFPDFPDFPDFPDF

The accounts for 4 older financial years, from 2002 to 2005, were filed as documents without figures as data, scans for example.

Source: Annual accounts 2013 (PDF), filed on 25-08-2014.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2013 full format 25-08-2014 2014-46300592 PDF
31-12-2012 full format 28-08-2013 2013-51100428 PDF
31-12-2011 full format 28-08-2012 2012-47600005 PDF
31-12-2010 full format 18-11-2011 2011-61300143 PDF
31-12-2009 abbreviated format 31-08-2010 2010-50200287 PDF
31-12-2008 abbreviated format 26-06-2009 2009-31500294 PDF
31-12-2007 abbreviated format 20-06-2008 2008-26800353 PDF
31-12-2006 abbreviated format 11-07-2007 2007-39500297 PDF
31-12-2005 full format 31-08-2006 2006-76202026 PDF
31-12-2004 full format 06-09-2005 2005-66703684 PDF
31-12-2003 full format 05-10-2004 2004-71101789 PDF
31-12-2002 full format 22-09-2003 2003-68201339 PDF

Insights on PHARMAFORM

The operating result for 2013 is 62% lower than in 2012 and the lowest since 2010. It is the second fall in a row.

Debt's share of the balance-sheet total falls from 83.9% to 83.5%. Equity is higher and debt is lower.